A Phase IIIb, multicenter, double-masked, randomized clinical trial comparing the efficacy and safey of Ranibizumab intravitreal injections versus Dexamethasone intravitreal implant in patients with visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).

Trial Profile

A Phase IIIb, multicenter, double-masked, randomized clinical trial comparing the efficacy and safey of Ranibizumab intravitreal injections versus Dexamethasone intravitreal implant in patients with visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).

Completed
Phase of Trial: Phase III

Latest Information Update: 22 May 2017

At a glance

  • Drugs Ranibizumab (Primary) ; Dexamethasone
  • Indications Central retinal vein occlusion; Retinal oedema
  • Focus Therapeutic Use
  • Acronyms COMRADE-C
  • Most Recent Events

    • 22 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top